Clinical Trial Update: IVIG in Patients With Severe COVID-19 Requiring Mechanical Ventilation [Phase 4]

View source ↗

Summary

Phase 4 trial updating IVIG use in severely ill COVID-19 patients requiring mechanical ventilation; status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars-cov Infection

Drugs mentioned

• IVIG (intravenous immunoglobulin)

Snippet

Sponsor: Sharp HealthCare | Conditions: Covid19, SARS-CoV Infection | Phase 4 | Status: UNKNOWN